CLDN2 and inflammatory bowel disease: Previous studies in inflammatory bowel disease have shown that butyrate may contribute to the restoration of the tight junction barrier by affecting the expression of Claudin‐2, Occludin, Cingulin, ZO‐1, and ZO‐2 [reviewed by Ploger et al. (2012)].